Markets:

Overview

News

Currencies

International

Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

24.76 -0.10 (-0.40%)

Streaming Delayed Price Updated: 11:14 AM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why a $104 Million Allocation to Eagle Materials Stock Could Signal Confidence in Construction’s Next Cycle ↗

February 14, 2026

This U.S. supplier serves construction and packaging markets with a diverse mix of cement, aggregates, wallboard, and paperboard.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Why a $183 Million Bet on FTI Consulting Signals Upside Potential Amid a 16% One-Year Drop ↗

February 14, 2026

FTI Consulting provides business advisory services worldwide, specializing in transformation, risk mitigation, and dispute resolution.

Via The Motley Fool

NICE Stock Down 38.5% as One Fund Dumps $32.75 Million. Here's What Investors Should Know ↗

February 14, 2026

This enterprise software provider delivers cloud-based AI solutions for customer engagement, compliance, and financial crime prevention.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market

February 12, 2026

Zoetis Inc. (NYSE: ZTS) stands today as the undisputed global leader in animal health, a position it has fortified since its historic decoupling from Pfizer over a decade ago. As of February 12, 2026,...

Via Finterra

Topics Artificial Intelligence Earnings Economy

1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

February 11, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border

February 05, 2026

In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...

Via MarketMinute

Topics Death Economy

2 Profitable Stocks to Own for Decades and 1 Facing Headwinds

January 26, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Mid-Cap Stocks with Open Questions

January 25, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

3 Reasons to Avoid ELAN and 1 Stock to Buy Instead

January 06, 2026

The past six months have been a windfall for Elanco’s shareholders. The company’s stock price has jumped 64.6%, setting a new 52-week high of $23.81 per share. This was partly thanks to its solid...

Via StockStory

1 Stock Under $50 on Our Buy List and 2 We Find Risky

December 28, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Topics Economy

3 Hyped Up Stocks with Warning Signs

December 24, 2025

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025

December 24, 2025

As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D...

Via MarketMinute

Topics Bonds Earnings World Trade

Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment

December 24, 2025

In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another...

Via MarketMinute

Black Creek Dumps 999,000 Shares of Baidu Stock Worth $49.1 Million ↗

December 17, 2025

The Baidu position now represents 4.93% of AUM, placing it outside the fund's top five holdings.

Via The Motley Fool

Topics Artificial Intelligence Economy

1 Cash-Producing Stock for Long-Term Investors and 2 We Brush Off

December 16, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Elanco (ELAN) Stock Is Up, What You Need To Know

December 16, 2025

Shares of animal health company Elanco (NYSE:ELAN) jumped 2.4% in the afternoon session after several top executives, including the CEO and CFO, disclosed significant purchases of company stock,...

Via StockStory

Topics Artificial Intelligence Government

Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies.

Via StockStory

Topics Economy Government

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

Black Creek’s Stake Reduction and the Larger Transition Unfolding Inside NICE’s Cloud and AI Platform ↗

November 21, 2025

NICE sits at the center of two critical enterprise markets: customer experience and financial crime prevention. This piece breaks down what is changing inside the business and why its next phase of...

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

1 Profitable Stock with Exciting Potential and 2 Facing Challenges

November 17, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

5 Revealing Analyst Questions From Elanco’s Q3 Earnings Call

November 12, 2025

Elanco's third quarter performance was marked by strong revenue growth across both pet and farm animal segments, with management highlighting U.S. Farm Animal up 20% and solid momentum in U.S. pet...

Via StockStory

Topics Earnings

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds

November 10, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

ELAN Q3 Deep Dive: Innovation Drives Growth, but Market Eyes Margin and Competition

November 06, 2025

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 10.4% year on year to $1.14 billion. Guidance for next quarter’s revenue was...

Via StockStory

1 Mid-Cap Stock for Long-Term Investors and 2 We Question

November 05, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Elanco Shares Poised For Upside After Another Quarter Of Outperformance ↗

November 05, 2025

Elanco posts strong Q3 results with 10% sales growth, surpasses forecasts, and raises full-year revenue and earnings guidance for 2025.

Via Benzinga

Elanco Animal Health (NYSE:ELAN) Beats Q3 Earnings Estimates and Raises Full-Year Outlook ↗

November 05, 2025

Elanco Animal Health (ELAN) beat Q3 2025 earnings estimates, raised its full-year guidance, and saw its stock rise on the strong results.

Via Chartmill

Elanco (NYSE:ELAN) Surprises With Q3 Sales

November 05, 2025

Animal health company Elanco (NYSE:ELAN) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $1.14 billion. Guidance for next quarter’s revenue was...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.